Xperix and Affiliates’ xPlus Stake Rises to 38.10%
Xperix and its affiliates’ xPlus stake rose to 38.10% after a convertible bond price adjustment.
Related stories
InspireMD to Announce Third-Quarter 2026 Results
InspireMD says it will announce its third-quarter 2026 financial results.
M impact | EQUITY | Oct 29, 2026, 12:01 PM UTC
Nasdaq Halts Trading in TJGC Group Limited
M impact | EQUITY | Oct 29, 2026, 12:00 PM UTC
DeFi Development Corp. to Announce Q3 2026 Results
DeFi Development Corp. said it will announce its third-quarter 2026 financial results.
M impact | EQUITY | Oct 29, 2026, 12:00 PM UTC
Investor Group Led by LTVCo Acquires Kipp
The acquisition is intended to accelerate Kipp’s US expansion and help card issuers and merchants recover declined transactions.
M impact | EQUITY | Oct 29, 2026, 12:00 PM UTC
MediWound to Report Third-Quarter 2026 Results
MediWound says it will report its third-quarter 2026 financial results.
M impact | EQUITY | Oct 29, 2026, 12:00 PM UTC
Geotab’s Altitude Selected for Washington Statewide Traffic Data Contract
Altitude by Geotab was selected as the vendor for a Washington statewide traffic data analysis contract, enabling eligible public sector organizations to purchase access to insight
L impact | EQUITY | Oct 29, 2026, 12:00 PM UTC